+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Afatinib Tablets Market - Global Forecast 2025-2030- Product Image
Afatinib Tablets Market - Global Forecast 2025-2030- Product Image
Sale

Afatinib Tablets Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6130726
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Afatinib tablets are redefining targeted oncology treatments by delivering irreversible ErbB receptor inhibition, setting a new benchmark in managing mutation-positive lung and head and neck cancers. As the sector navigates rapid innovation and evolving regulation, industry leaders must understand the multidimensional market segmentation, supply chain complexities, and emerging strategic alliances that shape this competitive landscape.

Market Snapshot: Afatinib Tablets Industry Outlook

The global Afatinib tablets market is experiencing sustained growth, supported by precision oncology integration, advancements in pharmaceutical formulation, and increasing adoption across diverse healthcare systems worldwide. Current estimates position the market as a vital segment within targeted therapy portfolios, driven by rising clinical demand among oncology specialists and nuanced engagement from payers responding to evolving value-based frameworks. Regionally, North America spearheads adoption due to established diagnostics infrastructure, while Asia-Pacific demonstrates robust volume growth linked to local incidences of oncologic disease and expanding healthcare access. The unique mechanism of Afatinib tablets continues to foster strong market positioning amidst intensifying competitive dynamics.

Scope & Segmentation

This executive report analyzes the Afatinib tablets market through comprehensive segmentation, unveiling key insights on product differentiation, distribution strategies, clinical applications, and regional diversity.

  • Product Type: Differentiates branded versus generic tablets, shaping pricing and lifecycle management strategies for all stakeholders.
  • Dosage Strength: Covers 20 mg, 30 mg, and 40 mg options, reflecting dosing flexibility for diverse patient needs.
  • Indication: Focuses on head and neck cancer as well as non-small cell lung cancer, each with distinct clinical pathways.
  • Distribution Channel: Maps hospital pharmacies (private, public), online pharmacies (direct-to-patient, third-party), and retail pharmacies (chain, independent).
  • Therapy Line: Considers both first-line and second-line therapy scenarios within modern oncology treatment paradigms.
  • Patient Type: Addresses adult, geriatric, and pediatric populations, with segment-specific safety and efficacy requirements.
  • Regional Scope: Includes Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).

Further, the report includes focused company analysis, capturing developments from leading players such as Boehringer Ingelheim International GmbH.

Key Takeaways for Decision-Makers

  • Personalized oncology and genetic profiling are now central to Afatinib tablet adoption, enabling optimized patient selection and improved clinical results.
  • Ongoing formulation innovation, such as novel coatings and sustained release mechanisms, enhances adherence and patient satisfaction in real-world settings.
  • Digital health integration supports robust monitoring of treatment outcomes, facilitating adaptive regimens and improved compliance with dosing schedules.
  • Patent strategies and pipeline collaborations are vital, as biosimilar and generic entrants accelerate market competition following branded exclusivity loss.
  • Local manufacturing alliances and dual sourcing protect against potential tariff shocks, reinforcing supply chain agility and continuity in the face of evolving international trade policies.
  • Region-specific clinical trials and adaptive pricing models increase the chances of successful market entry and payer acceptance across diverse healthcare landscapes.

Tariff Impact: U.S. 2025 Policy Adjustments

The scheduled United States tariff adjustments for 2025 directly impact Afatinib tablet supply chains, with expected shifts in raw material sourcing and manufacturing cost structures. Industry players are evaluating nearshoring strategies and renegotiating contracts to mitigate risk, which may affect pricing negotiations and reimbursement dynamics. Proactive engagement with policymakers is underway to safeguard access and stabilize supply, emphasizing the urgency of agile supply chain management to ensure uninterrupted patient care.

Primary Keyword: Afatinib Tablets

Afatinib tablets remain pivotal in precision oncology, largely due to their efficacy in mutation-driven cancer settings. Their evolving regulatory framework and ongoing competitive innovation make them a crucial focus for forward-thinking industry leaders.

Methodology & Data Sources

This market study synthesizes both primary and secondary sources, including structured interviews with industry experts, systematic literature reviews, and rigorous quantitative analysis of trade reports and healthcare data. Validation was achieved through triangulation and direct feedback from domain specialists, ensuring accuracy and integrity across all findings.

Why This Report Matters

  • Enables executives to benchmark product positioning and optimize strategic planning, particularly within the evolving landscape of targeted therapeutics.
  • Delivers actionable intelligence on supply chain resilience, tariff implications, and regional growth opportunities to safeguard market access and profitability.
  • Supports portfolio optimization and investment decisions by providing an authoritative, multidimensional view of clinical, regulatory, and operational dynamics.

Conclusion

Senior stakeholders equipped with these insights are strategically positioned to capitalize on emerging market opportunities, mitigate supply chain challenges, and reinforce their organizations’ leadership in the dynamic Afatinib tablets sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Impact of emerging patent expirations and generic afatinib launches on regional pricing dynamics
5.2. Evaluation of real-world efficacy and safety data of afatinib tablets in EGFR TKI-naïve patients
5.3. Integration of afatinib therapy with liquid biopsy diagnostics for personalized NSCLC treatment regimens
5.4. Strategic collaborations between biopharma companies and CROs to accelerate afatinib clinical development
5.5. Pricing and reimbursement landscape shifts driven by patient assistance programs for high-cost oncology drugs
5.6. Competitive pressure from third-generation EGFR inhibitors shaping afatinib market share and positioning
5.7. Expansion of emerging markets uptake driven by simplified dosing and patient support services for afatinib
5.8. Regulatory approvals for afatinib in combination therapy protocols across global oncology treatment guidelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Afatinib Tablets Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Afatinib Tablets Market, by Dosage Strength
9.1. Introduction
9.2. 20 Mg
9.3. 30 Mg
9.4. 40 Mg
10. Afatinib Tablets Market, by Indication
10.1. Introduction
10.2. Head Neck Cancer
10.3. Non Small Cell Lung Cancer
11. Afatinib Tablets Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Private
11.2.2. Public
11.3. Online Pharmacies
11.3.1. Direct To Patient
11.3.2. Third Party Platforms
11.4. Retail Pharmacies
11.4.1. Chain
11.4.2. Independent
12. Afatinib Tablets Market, by Therapy Line
12.1. Introduction
12.2. First Line
12.3. Second Line
13. Afatinib Tablets Market, by Patient Type
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Americas Afatinib Tablets Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Afatinib Tablets Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Afatinib Tablets Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Boehringer Ingelheim International GmbH
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. AFATINIB TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AFATINIB TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AFATINIB TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AFATINIB TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AFATINIB TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. AFATINIB TABLETS MARKET: RESEARCHAI
FIGURE 28. AFATINIB TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 29. AFATINIB TABLETS MARKET: RESEARCHCONTACTS
FIGURE 30. AFATINIB TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AFATINIB TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AFATINIB TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AFATINIB TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AFATINIB TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AFATINIB TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AFATINIB TABLETS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AFATINIB TABLETS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AFATINIB TABLETS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AFATINIB TABLETS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AFATINIB TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AFATINIB TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AFATINIB TABLETS MARKET SIZE, BY 30 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AFATINIB TABLETS MARKET SIZE, BY 30 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AFATINIB TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AFATINIB TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AFATINIB TABLETS MARKET SIZE, BY HEAD NECK CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AFATINIB TABLETS MARKET SIZE, BY HEAD NECK CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AFATINIB TABLETS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AFATINIB TABLETS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AFATINIB TABLETS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AFATINIB TABLETS MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AFATINIB TABLETS MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AFATINIB TABLETS MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AFATINIB TABLETS MARKET SIZE, BY CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AFATINIB TABLETS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AFATINIB TABLETS MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AFATINIB TABLETS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AFATINIB TABLETS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AFATINIB TABLETS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AFATINIB TABLETS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AFATINIB TABLETS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AFATINIB TABLETS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AFATINIB TABLETS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AFATINIB TABLETS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AFATINIB TABLETS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES AFATINIB TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. CANADA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 112. CANADA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 113. CANADA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. CANADA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 118. CANADA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 119. CANADA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 120. CANADA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 121. CANADA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 122. CANADA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 123. CANADA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 124. CANADA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 125. CANADA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 130. MEXICO AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 131. MEXICO AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. MEXICO AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 136. MEXICO AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 137. MEXICO AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 138. MEXICO AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 139. MEXICO AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 140. MEXICO AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 141. MEXICO AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA AFATINIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 222. GERMANY AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 223. GERMANY AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 224. GERMANY AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. GERMANY AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. GERMANY AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. GERMANY AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. GERMANY AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. GERMANY AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. GERMANY AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 232. GERMANY AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 233. GERMANY AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 234. GERMANY AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 235. GERMANY AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 240. FRANCE AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 241. FRANCE AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. FRANCE AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. FRANCE AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. FRANCE AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 246. FRANCE AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 247. FRANCE AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 248. FRANCE AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 249. FRANCE AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. FRANCE AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. FRANCE AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 252. FRANCE AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 253. FRANCE AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 273. ITALY AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. ITALY AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. ITALY AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 276. ITALY AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 277. ITALY AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. ITALY AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. ITALY AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. ITALY AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. ITALY AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. ITALY AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. ITALY AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. ITALY AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. ITALY AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. ITALY AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287. ITALY AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 288. ITALY AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 289. ITALY AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 290. ITALY AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 291. SPAIN AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. SPAIN AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. SPAIN AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 294. SPAIN AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 295. SPAIN AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. SPAIN AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. SPAIN AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. SPAIN AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. SPAIN AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 300. SPAIN AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 301. SPAIN AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 302. SPAIN AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 303. SPAIN AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 304. SPAIN AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 305. SPAIN AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 306. SPAIN AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 307. SPAIN AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 308. SPAIN AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 330. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY THERAPY LINE, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA AFATINIB TABLETS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (US

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Afatinib Tablets market report include:
  • Boehringer Ingelheim International GmbH

Related Topics

Related Reports

Afatinib API Market - Global Forecast 2025-2030 - Product Image

Afatinib API Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Olaparib Tablets Market - Global Forecast 2025-2030 - Product Image

Olaparib Tablets Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Nimesulide Dispersible Tablet Global Market Report 2025 - Product Image

Nimesulide Dispersible Tablet Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Isosorbide Mononitrate Tablet Global Market Report 2025 - Product Image

Isosorbide Mononitrate Tablet Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Tramadol Hydrochloride Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Tramadol Hydrochloride Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.